8 citations
,
June 1979 in “JAMA” This article discussed the ineffectiveness and dangers of implanting synthetic hair fibers for pattern baldness, noting they can cause severe infections, yet such clinics remain operational.
2 citations
,
June 1979 in “JAMA” This article reviews the ineffectiveness and potential dangers of synthetic fiber implantation for pattern baldness and reports no resolution of their ongoing use despite safety concerns.
25 citations
,
November 2022 in “British journal of dermatology/British journal of dermatology, Supplement” In this analysis, safety data from two clinical trials showed that baricitinib for severe alopecia areata had predictable side effects like infections and elevated CPK, with some serious adverse events noted at low incidence rates; no deaths were reported.
6 citations
,
February 2023 in “Advances in Therapy” This study found that patients with rheumatoid arthritis, atopic dermatitis, and alopecia areata receiving baricitinib had low incidence rates of adverse events, especially among low-risk individuals, with varying rates among those at higher risk.
January 2025 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.